Showing results (21-30 of 88) with videos related to
Sort By:
Pageof 9
Journal of Hypertension|May 2, 2001
Choice of drug treatment for obesity-related hypertension: where is the evidence?A M Sharma, T Pischon, S Engeli, et al.Der Nervenarzt|September 1, 1994
["Neuroadaptation" in long-term cannabis abuse. A clinical and electroencephalographic case study]G Winterer, L G Schmidt, K Frick, et al.Diabetologia|April 7, 2011
Association of changes in body mass index during earlier adulthood and later adulthood with circulating obesity biomarker concentrations in middle-aged men and womenJ Montonen, H Boeing, E Schleicher, et al.Neuroimage|February 9, 2010
Spontaneous brain activity and EEG microstates. A novel EEG/fMRI analysis approach to explore resting-state networksF Musso, J Brinkmeyer, A Mobascher, et al.Pharmacopsychiatry|May 25, 2006
Aripiprazole pharmacotherapy of borderline personality disorderA Mobascher, J Mobascher, V Schlemper, et al.Der Nervenarzt|September 1, 1995
[Optical and tactile hallucinosis as clinical onset of Creutzfeld-Jakob disease]A Heinz, L G Schmidt, G Winterer, et al.Hypertension (Dallas, Tex. : 1979)|March 7, 2001
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysisA M Sharma, T Pischon, S Hardt, et al.Biological Psychiatry|September 22, 2001
Event-related potentials and genetic risk for schizophreniaG Winterer, M F Egan, T Rädler, et al.Translational Psychiatry|June 14, 2012
Hippocampal subfields predict positive symptoms in schizophrenia: first evidence from brain morphometryS Kühn, F Musso, A Mobascher, et al.Pharmacopsychiatry|March 25, 2009
Distinct haplogenotypes of the dopamine D2 receptor gene are associated with non-smoking behaviour and daily cigarette consumptionC Wernicke, J Reese, A Kraschewski, et al.Pageof 9